Inhibition of Endothelial–Mesenchymal Transition Mediated by Activin Receptor Type IIA Attenuates Valvular Injury Induced by Group A Streptococcus in Lewis Rats
Background: Rheumatic heart disease (RHD), which is caused mainly by Group A Streptococcus, leads to fibrotic damage to heart valves. Recently, endothelial‒mesenchymal transition (EndMT), in which activin plays an important role, has been shown to be an important factor in RHD val...
Saved in:
Main Authors: | Zirong Lu, Yuan Li, Chuanghong Lu, Zhongyuan Meng, Ling Bai, Feng Huang, Zhiyu Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2025-01-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/30/1/10.31083/FBL26370 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
by: Elizabeth T. Evans, et al.
Published: (2024-09-01) -
Engineering aortic valves via transdifferentiating fibroblasts into valvular endothelial cells without using viruses or iPS cells
by: Peng Tang, et al.
Published: (2025-03-01) -
Overview of American Heart Association / American College of Cardiology guidelines 2017 for management of patients with valvular heart disease
by: M.Т. Vatutin, et al.
Published: (2017-12-01) -
The methods of treatment of atrial fibrillation in patients with valvular heart disease
by: O.M. Grytsay, et al.
Published: (2019-03-01) -
Transcatheter mitral valve replacement to treat rheumatic mitral stenosis: a case series
by: Ping Jin, et al.
Published: (2024-12-01)